Gene · 92521
Papers3,158
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,158
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Fragment-based screening targeting an open form of the SARS-CoV-2 main protease binding pocket. | Acta Crystallogr D Struct Biol | 2024 | 38289714 | PubTator, text mining | PubMed |
| SARS-CoV-2 and oncolytic EV-D68-encoded proteases differentially regulate pyroptosis. | J Virol | 2024 | 38289118 | PubTator, text mining | PubMed |
| Porcine deltacoronavirus nsp5 antagonizes type I interferon signaling by cleaving IFIT3. | J Virol | 2024 | 38289117 | PubTator, text mining | PubMed |
| On the origins of SARS-CoV-2 main protease inhibitors. | RSC Med Chem | 2024 | 38283212 | PubTator, text mining | PubMed |
| Antivirals for Broader Coverage against Human Coronaviruses. | Viruses | 2024 | 38275966 | PubTator, text mining | PubMed |
| Equine Rotavirus A under the One Health Lens: Potential Impacts on Public Health. | Viruses | 2024 | 38257830 | PubTator, text mining | PubMed |
| Leveraging SARS-CoV-2 Main Protease (Mpro) for COVID-19 Mitigation with Selenium-Based Inhibitors. | Int J Mol Sci | 2024 | 38256046 | PubTator, text mining | PubMed |
| G-Quadruplexes in the Regulation of Viral Gene Expressions and Their Impacts on Controlling Infection. | Pathogens | 2024 | 38251367 | PubTator, text mining | PubMed |
| Understanding the Neurotrophic Virus Mechanisms and Their Potential Effect on Systemic Lupus Erythematosus Development. | Brain Sci | 2024 | 38248274 | PubTator, text mining | PubMed |
Sequence analysis of the Spike, RNA-dependent RNA polymerase, and protease genes reveals a distinct evolutionary pattern of SARS-CoV-2 variants circulating in Yogyakarta and Central Java provinces, Indonesia. | Virus Genes | 2024 | 38244104 | PubTator, text mining | PubMed |
| Medicinal chemistry strategies towards the development of non-covalent SARS-CoV-2 Mpro inhibitors. | Acta Pharm Sin B | 2024 | 38239241 | PubTator, text mining | PubMed |
| Peptidyl nitroalkene inhibitors of main protease rationalized by computational and crystallographic investigations as antivirals against SARS-CoV-2. | Commun Chem | 2024 | 38238420 | PubTator, text mining | PubMed |
| Targeting the Main Protease (Mpro, nsp5) by Growth of Fragment Scaffolds Exploiting Structure-Based Methodologies. | ACS Chem Biol | 2024 | 38232960 | PubTator, text mining | PubMed |
| Successful treatment of SARS-CoV-2 in an immunocompromised patient with persistent infection for 245 days: A case report. | Heliyon | 2024 | 38223743 | PubTator, text mining | PubMed |
| Cryptosporidium infection of human small intestinal epithelial cells induces type III interferon and impairs infectivity of Rotavirus. | Gut Microbes | 2024 | 38189373 | PubTator, text mining | PubMed |
| Grass carp reovirus VP56 and VP35 induce formation of viral inclusion bodies for replication. | iScience | 2024 | 38188516 | PubTator, text mining | PubMed |
| Omicron and Delta variant prevalence detection and identification during the fourth COVID-19 wave in Mexico using wastewater-based epidemiology. | IJID Reg | 2024 | 38149263 | PubTator, text mining | PubMed |
| Clinical development of antivirals against SARS-CoV-2 and its variants. | Curr Res Microb Sci | 2024 | 38149085 | PubTator, text mining | PubMed |
| Inhibition of SARS-CoV-2 NSP-15 by Uridine-5'-Monophosphate Analogues Using QSAR Modelling, Molecular Dynamics Simulations, and Free Energy Landscape. | Saudi Pharm J | 2024 | 38111672 | PubTator, text mining | PubMed |
| Retraction. | Cancer Med | 2024 | 38108531 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/papers?page=9